{
  "ticker": "REGN",
  "year": 2024,
  "quarter": 3,
  "last_updated": "2025-04-19T08:13:02.121868",
  "count": 17,
  "transactions": [
    {
      "id": 110503,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 110551,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110533,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 110542,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 110529,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 110530,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 110506,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 110508,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110495,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 110509,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 110526,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 86304,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 110536,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 86280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 86309,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 110505,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 110541,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    }
  ]
}